Table 2. Risk factors associated with hepatocellular carcinoma recurrence.
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
P value | HR (95% CI) | P value | ||
Pretransplant factor | ||||
Pre-treatment therapies | 0.4200 | |||
Tumor number ≥2 | 0.0900 | |||
Tumor size ≥2.0 cm | 0.0400 | |||
Within Milan criteria | 0.0400 | |||
Within Tokyo criteria | 0.0001 | 0.08 (0.01–0.66) | 0.0141 | |
Alpha-fetoprotein ≥400 ng/mL | <0.0001 | 11.00 (2.09–58.41) | 0.0047 | |
Des-gamma-carboxy prothrombin ≥200 mAU/mL | 0.0010 | 6.20 (1.31–29.45) | 0.0217 | |
Graft type; right/left | 0.6100 | |||
Graft volume to standard liver volume ≥40% | 0.8300 | |||
Posttransplant factor | ||||
Tumor number ≥2 | 0.0700 | |||
Tumor size ≥2.0 cm | 0.3400 | |||
Within Milan criteria | 0.5700 | |||
Within Tokyo criteria | 0.9300 | |||
Microvascular invasion | 0.0040 |
CI, confidence interval; HR, hazard ratio.